Center-Authored Papers

Filters: Author is Ulrich, Cornelia M  [Clear All Filters]
Journal Article
Reding KW, Lampe JW, Wang C-Y, Stanczyk FZ, Ulrich CM, Xiao L, Duggan CR, McTiernan A.  2011.  A 12-month moderate-intensity exercise intervention does not alter serum prolactin concentrations.. Cancer epidemiology. 35(6):569-73. Abstract
De Roos AJ, Ulrich CM, Sjodin A, McTiernan A.  2012.  Adiposity, body composition, and weight change in relation to organochlorine pollutant plasma concentrations.. Journal of exposure science & environmental epidemiology. Abstract
Liesenfeld DB, Botma A, Habermann N, Toth R, Weigel C, Popanda O, Klika KD, Potter JD, Lampe JW, Ulrich CM.  2015.  Aspirin Reduces Plasma Concentrations of the Oncometabolite 2-Hydroxyglutarate: Results of a Randomized, Double-Blind, Crossover Trial.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Curtin K, Samowitz WS, Wolff RK, Ulrich CM, Caan BJ, Potter JD, Slattery ML.  2009.  Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(12):3384-8. Abstract
Wayne S, Neuhouser ML, Ulrich CM, Koprowski C, Wiggins C, Baumgartner KB, Bernstein L, Baumgartner RN, Gilliland F, McTiernan A et al..  2008.  Association between alcohol intake and serum sex hormones and peptides differs by tamoxifen use in breast cancer survivors.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(11):3224-32. Abstract
Campbell PT, Newton CC, Newcomb PA, Phipps AI, Ahnen DJ, Baron JA, Buchanan DD, Casey G, Cleary SP, Cotterchio M et al..  2015.  Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotype.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(8):1229-38. Abstract
Nan H, Hutter CM, Lin Y, Jacobs EJ, Ulrich CM, White E, Baron JA, Berndt SI, Brenner H, Butterbach K et al..  2015.  Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.. JAMA. 313(11):1133-42. Abstract
Villaseñor A, Ballard-Barbash R, Ambs A, Bernstein L, Baumgartner K, Baumgartner R, Ulrich CM, Hollis BW, McTiernan A, Neuhouser ML.  2013.  Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors.. Cancer causes & control : CCC. 24(4):759-67. Abstract
Zschäbitz S, Cheng T-YD, Neuhouser ML, Zheng Y, Ray RM, Miller JW, Song X, Maneval DR, Beresford SAA, Lane D et al..  2013.  B vitamin intakes and incidence of colorectal cancer: results from the Women's Health Initiative Observational Study cohort.. The American journal of clinical nutrition. 97(2):332-43. Abstract
Toriola AT, Cheng T-YD, Neuhouser ML, Wener MH, Zheng Y, Brown E, Miller JW, Song X, Beresford SAA, Gunter MJ et al..  2013.  Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers.. International journal of cancer. Journal international du cancer. 132(11):2648-58. Abstract
Abbenhardt C, Miller JW, Song X, Brown EC, Cheng T-YD, Wener MH, Zheng Y, Toriola AT, Neuhouser ML, Beresford SAA et al..  2014.  Biomarkers of One-Carbon Metabolism Are Associated with Biomarkers of Inflammation in Women.. The Journal of nutrition. 144(5):714-21. Abstract
Beyerle J, Frei E, Stiborova M, Habermann N, Ulrich CM.  2015.  Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer.. Drug metabolism reviews. :1-23. Abstract
Wayne SJ, Neuhouser ML, Koprowski C, Ulrich CM, Wiggins C, Gilliland F, Baumgartner KB, Baumgartner RN, McTiernan A, Bernstein L et al..  2009.  Breast cancer survivors who use estrogenic botanical supplements have lower serum estrogen levels than non users.. Breast cancer research and treatment. 117(1):111-9. Abstract
Poole EM, Bigler J, Whitton J, Sibert JG, Potter JD, Ulrich CM.  2009.  C-reactive protein genotypes and haplotypes, polymorphisms in NSAID-metabolizing enzymes, and risk of colorectal polyps.. Pharmacogenetics and genomics. 19(2):113-20. Abstract
Freedman AN, Sansbury LB, Figg WD, Potosky AL, Weiss Smith SR, Khoury MJ, Nelson SA, Weinshilboum RM, Ratain MJ, McLeod HL et al..  2010.  Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation.. Journal of the National Cancer Institute. 102(22):1698-705. Abstract
Levine JA, Figueiredo JC, Lee W, Conti DV, Kennedy K, Duggan DJ, Poynter JN, Campbell PT, Newcomb PA, Martinez ME et al..  2010.  A candidate gene study of folate-associated one carbon metabolism genes and colorectal cancer risk.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 19(7):1812-21. Abstract
Curtin K, Ulrich CM, Samowitz WS, Wolff RK, Duggan DJ, Makar KW, Caan BJ, Slattery ML.  2011.  Candidate pathway polymorphisms in one-carbon metabolism and risk of rectal tumor mutations.. International journal of molecular epidemiology and genetics. 2(1):1-8. Abstract
Klassen O, Schmidt ME, Scharhag-Rosenberger F, Sorkin M, Ulrich CM, Schneeweiss A, Potthoff K, Steindorf K, Wiskemann J.  2014.  Cardiorespiratory fitness in breast cancer patients undergoing adjuvant therapy.. Acta oncologica (Stockholm, Sweden). :1-10. Abstract
Campbell PT, Jacobs ET, Ulrich CM, Figueiredo JC, Poynter JN, McLaughlin JR, Haile RW, Jacobs EJ, Newcomb PA, Potter JD et al..  2010.  Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status.. Journal of the National Cancer Institute. 102(6):391-400. Abstract
Liesenfeld DB, Habermann N, Toth R, Owen RW, Frei E, Böhm J, Schrotz-King P, Klika KD, Ulrich CM.  2015.  Changes in urinary metabolic profiles of colorectal cancer patients enrolled in a prospective cohort study (ColoCare). Metabolomics. 11(4):998-1012. Abstract
Hutter CM, Chang-Claude J, Slattery ML, Pflugeisen BM, Lin Y, Duggan D, Nan H, Lemire M, Rangrej J, Figueiredo JC et al..  2012.  Characterization of gene-environment interactions for colorectal cancer susceptibility loci.. Cancer research. 72(8):2036-44. Abstract
Boffetta P, Colditz GA, Potter JD, Kolonel L, Robson PJ, Malekzadeh R, Seminara D, Goode EL, Yoo K-Y, Demers P et al..  2011.  Cohorts and consortia conference: a summary report (Banff, Canada, June 17-19, 2009).. Cancer causes & control : CCC. 22(3):463-8. Abstract
Ramsey SD, Holmes RS, McDermott CL, Blough DK, Petrin KL, Poole EM, Ulrich CM.  2012.  A Comparison of Approaches for Association Studies of Polymorphisms and Colorectal Cancer Risk.. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. Abstract
Gray-McGuire C, Guda K, Adrianto I, Lin CP, Natale L, Potter JD, Newcomb PA, Poole EM, Ulrich CM, Lindor N et al..  2010.  Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22.. Cancer research. 70(13):5409-18. Abstract
Fiederling J, Ulrich CM, Hemminki K, Haug U.  2013.  Consideration of family history of cancer in medical routine: a survey in the primary care setting in Germany.. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). Abstract